Changing Bio recently completed its A+ funding round, bringing the total funding raised to nearly 300 million yuan since 2022. Changing Bio is the leading unit of the Synthetic Biology Professional Committee of the Shanghai Biopharmaceutical Industry Association and also serves as the implementing unit of the Food Synthetic Biology Innovation Center, affiliated with the same association. The company has established the Joint Laboratory for Innovative Food with the National Key Laboratory of Food Science and Technology at Nanchang University, focusing on the application and research of synthetic biology in the food sector. Changing Bio is currently focused on the emerging field of novel food proteins and has secured over 10 patents and numerous technical secrets. Their current strategy involves a dual-track development approach, which includes precision fermentation for bio-synthesized proteins and microbial proteins derived from biomass fermentation.
The first production line for microbial protein derived from biomass fermentation has obtained food production permits and commenced production. It has also received several quality certifications, including BRC (British Retail Consortium), FSSC22000, ISO22000, and HACCP. Additionally, the company has installed two large-scale production line equipment, which are currently in the process of being interconnected. It is expected that this year, the company will achieve large-scale production and launch products into the market.
In the field of precision fermentation proteins based on synthetic biology technology, Changing Bio has successfully achieved the bio-synthesis of whey proteins from various mammalian species, including cows, sheep, pandas, whales, dolphins, cats, and dogs. These achievements come with independent intellectual property rights.
Disclaimer: Despite our efforts to maintain accuracy, errors are unavoidable due to our limited expertise. Some information may not be up to date, and we welcome your feedback to make necessary corrections. This document is intended solely for the purpose of providing a business-oriented and written introduction to the field of synthetic biology. It does not constitute any investment advice. We appreciate your understanding.